Over the past few years, artificial intelligence—or AI—has started to revolutionize the world as we know it: some people now ask AI-based chatbots to write essays and summarize documents, others use AI-powered virtual ...
Oct 17, 2023
0
60
The brains of people who reduce their drinking, as well as of people who quit drinking entirely, have greater volume in certain regions than people who drink more heavily, according to a new study of adults treated for alcohol ...
Oct 16, 2023
0
4
Neurons, the main cells that make up our brain and spinal cord, are among the slowest cells to regenerate after an injury, and many neurons fail to regenerate entirely. While scientists have made progress in understanding ...
Oct 16, 2023
0
158
Zaher Elbeck from ICMC at the Department of Medicine, Huddinge (MedH) is defending his thesis, titled "Redox and epigenetic modulators regulate cardiac function and remodeling in health and disease," on 16 October 2023. The ...
Oct 10, 2023
0
8
Certain characteristics of people seeking remission from alcohol use disorder (AUD) are linked to their choice of recovery meeting, a new study suggests. Informal peer recovery groups—mutual-help organizations—play a ...
Oct 9, 2023
0
0
Drinking coffee and tea at midlife may be associated with a reduced likelihood of physical frailty in late life. A Singapore study has shown that adults, who consumed higher intake of caffeine via the drinking of coffee or ...
Oct 6, 2023
0
37
Sleep is a vital aspect of human life, with deep sleep being particularly crucial for overall health. The brain recovers during this sleep stage, and the rest of the body seems to regenerate then as well.
Oct 5, 2023
0
2
What if a vaccine, given to patients just before or after arriving at the hospital, could protect them against lethal superbugs that lurk in health care settings?
Oct 4, 2023
0
32
An advisory panel to the U.S. Food and Drug Administration on Wednesday voted resoundingly against recommending a stem cell-based experimental treatment for ALS.
Sep 28, 2023
0
31
Researchers at Baylor College of Medicine have developed a new compound called d16 that can reduce tumor growth and overcome therapeutic resistance in mutant p53-bearing cancers in the lab. The findings, published in the ...
Sep 27, 2023
0
9
